Synergistic Antitumor Efficacy of Radiofrequency Ablation Combined With <scp>TROP2</scp> ‐ <scp>CAR</scp> ‐T Cells in a Xenograft Mouse Model of Lung Adenocarcinoma

The combination of RFA and TROP2-CAR-T therapy demonstrates enhanced antitumor efficacy and improved safety profile in LUAD, highlighting a promising combinatorial immunotherapeutic approach.